Clinical Trial Results TV
April 12, 2006: Embolic Protection and Thrombectomy: If Yes, When, Who and How
This video is sponsored by the Duke Clinical Medical Series.

Topics include:
* Case Presentation
* Embolic Protection and Thrombectomy If Yes: When, Who, and How?
* Outline
* Microembolization During Interventions (ACS)
* SAFER Angiographic Predictors % Graft Diseased, Plaque Volume, Rx
* Outline
* Embolic Protection Devices
* SAFER Primary Endpoint 30-day MACE (N = 801)
* EMERALD: Infarct Size By Tc-99m SPECT (Infarct Size; % LV)
* TriActiv System Key Components

The moderator, Peter Berger, MD, has indicated that he receives research/grant support
from Aventis, Conor, Guilford, Lumen, and Velocimed. Dr. Berger is also a member of an
advisory board for Genentech and Cordis/Johnson & Johnson; he has spoken at scientific
symposia for Aventis, Bristol-Myers Squibb, Genentech, and Guilford. Dr. Berger also
serves as Medical Director and has equity with Lumen, Inc.

The guest faculty, James Hermiller, MD, has indicated that he receives research/grant
support from Cordis/Johnson & Johnson, Medtronic, BSC, and Guidant. He is a consultant
for BSC, Guidant, and Anhoff.

n/a



Embolic Protection and Thrombectomy: If Yes, When, Who and How

Please select your viewing options:

Windows Media: 56k 100k
RealPlayer: 56k 100k
Number Viewing:
Need a media player? Please choose one of the free downloads below:
Get Windows Media PlayerDownload RealPlayer

Video Statistics
0 out of 5

1 Star 2 Star 3 Star 4 Star 5 Star

click a star to vote
This submission has received 0 total votes.

These statistics are updated nightly. The last update ran on
10-18-2021 EST at 1 am.

Additional Files
Filename File Description Action
No additional files available

Comments [ login to comment ]
No comments have been submitted